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Summary
Background: Chlamydia trachomatis and Neisseria gonorrhoeae are two important and fre-
quently overlooked causes of neonatal and adult conjunctivitis.
Objectives and methods: In order to improve primary treatment, prevention, and control of
infection caused by these organisms, an analysis of all cases presenting from July 2002 to
December 2006 at a major Irish regional teaching hospital was performed.
Results: There were 51 cases of conjunctivitis in total. Among neonates and adults, C. tracho-
matis was the most common cause of conjunctivitis. Of the adult patients, 75% were men. The
annual incidence of adult chlamydial conjunctivitis increased yearly from 2002 and correlated
with an overall increase in genital chlamydia infection in the region. Neonatal chlamydial
conjunctivitis has an overall incidence of 0.65/1000 live births and is continuing to rise annually.
In 2006, gonococcal conjunctivitis accounted for 20% of all cases of conjunctivitis caused by
sexually transmitted bacteria presenting to our hospital.
Conclusions: The recent increase in the incidence of gonococcal keratitis serves to remind us that
this important infection should be borne in mind when treating cases of purulent conjunctivitis.
The diagnosis of chlamydial and gonococcal conjunctivitis requires a high index of suspicion and
prompt treatment with systemic antibiotics.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Genital infection with Chlamydia trachomatis is the most
common sexually transmitted bacterial infection world-Corresponding author. Tel.: +353 21 4920030;
x: +353 21 4922656.
E-mail address: mmmquirke@hotmail.com (M. Quirke).
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i:10.1016/j.ijid.2007.09.013wide.1 The incidence in Ireland increased over 10-fold
between 1995 and 2004,2 and continues to rise on an annual
basis. C. trachomatis infection of the eye may cause focal
corneal scarring, neovascularization, and chronic inclusion
conjunctivitis, which in the neonate may lead to otitis media
and pneumonitis.3
Neisseria gonorrhoeae infection is a rare but important
cause of keratoconjunctivitis, which may rapidly penetratePublished by Elsevier Ltd. All rights reserved.
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Figure 2 Annual incidence of adult chlamydial conjunctivitis
in the Cork region.the intact cornea leading to endophthalmitis. Vertical trans-
mission to the neonate may occasionally lead to meningitis,
endocarditis, and septic arthritis.4
We examined the annual incidence of chlamydial and
gonococcal conjunctivitis among adults and neonates pre-
senting at a major regional teaching hospital in Ireland. The
identification and treatment of these increasingly more
common infections is relevant to ophthalmologists, pediatri-
cians, and general practitioners.
Methods
We examined all cases of conjunctivitis caused by C. tracho-
matis and N. gonorrhoeae that were analyzed at Cork Uni-
versity Hospital between July 2002 and December 2006.
Patients included inpatient and outpatient neonates under
30 days old and adults of all ages. Demographic information
was retrieved from patient files and compiled on Microsoft
Excel. Data concerning the regional incidence of genital
chlamydia and gonococcal infections were retrieved from
the local sexually transmitted infections clinic.
C. trachomatis was detected by polymerase chain reac-
tion (PCR) using Roche Amplicor. Specimens were taken with
a plastic unishaft swab and transported in prepared media at
2—8 8C (Remel MicroTestTM M4RT1 Transport). N. gonor-
rhoeae was detected by Gram staining of conjunctival secre-
tions and subsequent culture and sensitivity testing on
chocolate agar.
Results
Between July 2002 and December 2006 there were 51 cases of
conjunctivitis caused by sexually transmitted organisms,
affecting 33 adults and 18 neonates (see Figure 1). C. tra-
chomatis was cultured in 48 cases and N. gonorrhoeae in 3
cases.
Among adults,C. trachomatiswas themost common organ-
ism isolated (94%). Of the adult patients, 75% were men
ranging in age from 16 to 78 years, with a mean age of 27.3
years. Women accounted for 25% of adult cases and ranged in
age from 16 to 31 years, with a mean age of 21.5 years.
The annual incidence of adult chlamydial conjunctivitis
increased yearly from 2002, with the greatest number of
cases detected in 2005 (n = 13). Data from the regional
sexually transmitted infections unit also show a peak occur-
rence of genital chlamydia infection in 2005 with a decrease
in incidence in 2006 (see Figures 2 and 3). There were two
cases of adult gonococcal conjunctivitis cultured betweenFigure 1 Adult versus neonatal conjunctivitis.2005 and 2006. These patients were male, both under 21
years of age. In 2006, gonococcal conjunctivitis accounted
for 20% of all cases of conjunctivitis caused by sexually
transmitted bacteria presenting at our hospital.
There were 18 cases of neonatal conjunctivitis during the
study period. C. trachomatis was cultured in 17 cases. The
overall annual incidence of neonatal chlamydial conjuncti-
vitis in this region was 0.65/1000 live births. Unlike the
trends observed in the adult population, the incidence of
neonatal conjunctivitis continued to rise after 2005 (see
Figure 1). The average age of presentation of neonates with
chlamydial conjunctivitis was 14 days. The ratio of male to
female infants infected with C. trachomatis was 1:1.
There was one case of gonococcal keratoconjunctivitis in a
4-day-old female neonate giving an overall incidence of 0.04/
1000 live births during the study period.
Discussion
Our data show that the annual incidence of adult chlamydial
conjunctivitis is increasing and correlates with the annual
incidence of genital chlamydial infection in the region. Young
men accounted for 75% of all cases of chlamydial conjuncti-
vitis. This contrasts with data pertaining to genital chlamydia
over the same timeperiod,which reveal that 54.2% of all cases
of genital chlamydial infection occurred in female patients.
There is general consensus that ocular infection in adults
results from autoinnoculation of infected genital secretions
from the patient or from his/her partner.5,6 Stenberg and
Mardh showed that up to 77% of patients with symptomatic
ocular infection have positive concomitant genital infection.6
Neonatal conjunctivitis has been defined as inflammation
of the conjunctiva from infectious or toxic causes occurring
within the first thirty days of life. C. trachomatis and
N. gonorrhoeae infections are usually transmitted to theFigure 3 Annual incidence of adult genital chlamydia in the
Cork region.
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ing parturition.3
C. trachomatis is the most common sexually transmitted
organism to cause neonatal conjunctivitis. The incidence in
this region is similar to the incidence quoted from other
developed countries, which ranges from 0.78 (Di Bartolomeo
et al.7) to 8 (Hammerschlag8) per 1000 live births. Pooling
data from studies published between 1977 and 1999, Rosen-
man et al. showed that among infants exposed to C. tracho-
matis at birth, the point estimate of the incidence of
conjunctivitis was 15% and of pneumonia was 7%.9 The risk
of a neonate acquiring gonococcal conjunctivitis following
exposure is estimated to be between 30% and 50%.10
Although the ocular application of topical 0.5% erythro-
mycin, 1.0% tetracycline, or 1.0% silver nitrate is effective in
reducing the incidence of neonatal gonococcal conjunctivi-
tis, it has been shown that all three prophylactic agents do
not significantly reduce the incidence of neonatal chlamydial
conjunctivitis.11 However, in areas in which the screening and
treatment of maternal genital chlamydial infection is carried
out, the prevalence of neonatal chlamydial conjunctivitis has
decreased.12 Thus the best method of preventing neonatal
chlamydial conjunctivitis is by treating infected mothers
before delivery.3
Gonococcal conjunctivitis is rare in developed countries.
The incidence of neonatal gonococcal conjunctivitis in our
series (0.04/1000 live births) is similar to that quoted in
Western Europe in the 1990s.13
C. trachomatis infection of the conjunctiva has an incu-
bation period of 5—14 days after which the development of
conjunctival erythema and scanty mucoid discharge is char-
acteristic. Chemosis, pseudomembrane formation, and
severe mucopurulent or bloody dischargemay develop. When
present, bloody discharge is highly specific for chlamydial
infection.14 Untreated infection may result in corneal and
conjunctival scarring.
Infection with N. gonorrhoeae is characterized by the
development of severe purulent conjunctival discharge, a
short incubation period (2—5 days), rapid corneal penetra-
tion, and endophthalmitis.
Both chlamydial and gonococcal keratoconjunctivitis in
either the adult or neonate require prompt systemic treat-
ment. Topical treatment alone is inadequate (since it will not
eliminate concurrent nasopharyngeal infection) and unne-
cessary when systemic treatment is given. The failure rate of
oral erythromycin for neonatal chlamydial conjunctivitis or
pneumonia is approximately 20%. A second course of treat-
ment may be required.15
In conclusion, C. trachomatis and N. gonorrhoeae are
important causes of adult and neonatal conjunctivitis. Our
data show that the increase in detected cases of chlamydial
conjunctivitis was mostly among young adult men and corre-
lated with an overall increase in genital chlamydia infection in
the region. Neonatal chlamydial conjunctivitis remains ende-
mic. A screening program directed at high risk women of child
bearing agemaybemost effective in reducing the incidence of
neonatal chlamydial conjunctivitis further. The recent incre-
ase in the incidence of gonococcal keratitis serves to remind us
that this important infection should be borne in mind when
treating cases of purulent conjunctivitis. The diagnosis of
chlamydial and gonococcal conjunctivitis requires a high index
of suspicion and prompt treatment with systemic antibiotics.Acknowledgements
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